TrademarkDir
BIOECLIPSE
LIVE

Serial Number

87398361

Owner

ConcentRx, Inc.

Attorney

Joyce Liou

First Use Date

Sep 29, 2020

Filing Date

Apr 4, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

BIOECLIPSE Trademark

Serial Number: 87398361 • Registration: 6341819

BIOECLIPSE is a trademark filed by ConcentRx, Inc. on April 4, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

ConcentRx, Inc. (4 trademarks)

319 N. Bernardo Ave.
Mountain View, CA 94043

Entity Type: 03

BIOECLIPSE THERAPEUTICS, INC. (2 trademarks)

MOUNTAIN VIEW, CA 94043

Entity Type: 03

Trademark Details

Filing Date

April 4, 2017

Registration Date

May 4, 2021

First Use Anywhere

September 29, 2020

First Use in Commerce

September 29, 2020

Published for Opposition

August 8, 2017

Goods & Services

Immunotherapies for the treatment of cancer; pharmaceuticals for the treatment of cancer

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 4, 2026 REM1
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 12, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 12, 2024 REAP
REGISTERED-PRINCIPAL REGISTER
May 4, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 30, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 27, 2021 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 8, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 7, 2021 TROA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 21, 2020 ASGN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 9, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 9, 2020 GNRT
SU - NON-FINAL ACTION - WRITTEN
Oct 9, 2020 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Oct 8, 2020 SUPC
USE AMENDMENT FILED
Oct 5, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 5, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 4, 2020 EXRA
SOU EXTENSION 5 GRANTED
Apr 3, 2020 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 3, 2020 AITU
SOU EXTENSION 5 FILED
Apr 1, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Apr 1, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 5, 2019 EXRA
SOU EXTENSION 4 GRANTED
Oct 3, 2019 EX4G
SOU EXTENSION 4 FILED
Oct 3, 2019 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 3, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 4, 2019 EXRA
SOU EXTENSION 3 GRANTED
Apr 2, 2019 EX3G
SOU EXTENSION 3 FILED
Apr 2, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 2, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 5, 2018 EXRA
SOU EXTENSION 2 GRANTED
Oct 3, 2018 EX2G
SOU EXTENSION 2 FILED
Oct 3, 2018 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 3, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 9, 2018 EXRA
SOU EXTENSION 1 GRANTED
Feb 7, 2018 EX1G
SOU EXTENSION 1 FILED
Feb 7, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 7, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 3, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 8, 2017 NPUB
PUBLISHED FOR OPPOSITION
Aug 8, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 19, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 26, 2017 CNSA
ASSIGNED TO EXAMINER
Jun 26, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 10, 2017 NWOS
NEW APPLICATION ENTERED
Apr 7, 2017 NWAP

Related Trademarks

More from this Owner

CONCENTRX

CONCENTRX

CONCENTRX

CONCENTRX

TARGETED BIOTHERAPY

TARGETED BIOTHERAPY

BIOECLIPSE THERAPEUTICS

BIOECLIPSE THERAPEUTICS

BIOECLIPSE THERAPEUTICS

BIOECLIPSE THERAPEUTICS

BIOECLIPSE THERAPEUTICS

BIOECLIPSE THERAPEUTICS